Bionovo (BNVI) Reports Q3 Loss of $0.05
More News related to BNVI
- Dr. Paul Pui-Hay But, Ph.D. Joins Bionovo, Inc. Scientific Advisory Board
- Biotech Stock Alert for Bionovo Inc. Issued by StockPreacher
- Morning Movers 01/14: ETRM, LAB, TSTR, CROX, HEB Higher; ROSG, MRNA, IPII, MED Lower
- Bionovo (BNVI) Published Phase 1B of Bezielle; Safe and Well Tolerated in Metastatic Breast Cancer Patients
- Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
More News related to Earnings
- Forrester Research (FORR) Posts Q4 EPS of $0.35 Tops by 7c; Guides Q110 and FY10
- NetSol (NTWK) Reports Q2 Loss of $0.01, Misses by 2c; Reaffirms Guidance
- Rentech (RTK) Reports Q1 Loss of $0.07
- Textainer (TGH) Tops Q4 Earnings Views
- Sprint Nextel (S) Q4 Losses Narrow, But Miss Expectations
Bionovo Inc. (NASDAQ: BNVI) reports Q3 EPS of $0.05 loss, in-line analyst estimate of ($0.05). Revenue for the quarter was $155K
Related Categories
EarningsStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
